| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 53.00M | 53.00M | 64.00M | 40.20M | 24.46M |
| Gross Profit | 36.10M | 36.10M | 47.00M | 24.30M | 16.31M |
| EBITDA | 36.10M | -64.10M | 49.40M | 33.80M | 52.93M |
| Net Income | -88.80M | -88.80M | 6.90M | 20.20M | 49.61M |
Balance Sheet | |||||
| Total Assets | 1.27B | 1.27B | 1.44B | 1.72B | 693.60M |
| Cash, Cash Equivalents and Short-Term Investments | 40.50M | 40.50M | 19.90M | 7.60M | 2.69M |
| Total Debt | 448.30M | 448.30M | 481.10M | 703.70M | 22.29M |
| Total Liabilities | 478.30M | 478.30M | 521.50M | 766.20M | 39.51M |
| Stockholders Equity | 788.00M | 788.00M | 912.60M | 951.20M | 654.09M |
Cash Flow | |||||
| Free Cash Flow | 23.30M | 18.30M | 6.40M | 888.90M | -473.92M |
| Operating Cash Flow | 23.30M | 18.30M | 6.40M | 11.10M | 19.96M |
| Investing Cash Flow | 78.90M | 83.90M | 41.50M | -961.90M | -522.47M |
| Financing Cash Flow | -81.60M | -81.60M | -35.60M | 944.10M | 501.58M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | AU$743.50M | 13.85 | 24.81% | 3.77% | 11.19% | 34.96% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | AU$409.14M | 10.39 | 7.93% | 7.08% | -3.97% | 1057.09% | |
53 Neutral | AU$695.90M | -35.20 | -1.91% | 8.45% | -4.50% | 88.28% | |
53 Neutral | AU$64.11M | ― | -23.55% | 14.36% | -68.24% | 42.03% | |
52 Neutral | AU$418.13M | -4.72 | -10.44% | 11.14% | -16.67% | -1419.67% | |
46 Neutral | AU$100.29M | -21.45 | -2.01% | 3.63% | -5.21% | -14350.00% |
HealthCo Healthcare & Wellness REIT has released its Annual Report for the year ending 30 June 2025. This report, authorized by the Board of the Responsible Entity, will be distributed to unitholders who opted to receive it. The announcement underscores HCW’s commitment to maintaining transparency and providing stakeholders with insights into its financial performance and strategic direction.
The most recent analyst rating on (AU:HCW) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on HealthCo Healthcare & Wellness REIT stock, see the AU:HCW Stock Forecast page.
HealthCo Healthcare and Wellness REIT announced a change in the director’s interest, with Director Natalie Jane Meyenn acquiring 25,565 fully paid ordinary units, increasing her total to 161,005 units. This acquisition is part of a voluntary non-executive director unit acquisition arrangement, indicating a strategic move to align director interests with company performance, potentially impacting stakeholder confidence positively.
The most recent analyst rating on (AU:HCW) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on HealthCo Healthcare & Wellness REIT stock, see the AU:HCW Stock Forecast page.
HealthCo Healthcare and Wellness REIT announced a change in the director’s interest notice, revealing that Director Kelly O’Dwyer has acquired 21,658 fully paid ordinary units at $0.78 per unit. This acquisition is part of the FY25 voluntary non-executive director unit acquisition arrangement, indicating the director’s increased stake in the company, which could signal confidence in the company’s future performance.
The most recent analyst rating on (AU:HCW) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on HealthCo Healthcare & Wellness REIT stock, see the AU:HCW Stock Forecast page.
HealthCo Healthcare & Wellness REIT announced a change in the director’s interest, with Joseph Carrozzi AM acquiring an additional 21,047 fully paid ordinary units, bringing his total to 435,612 units. This acquisition was part of the company’s voluntary non-executive director unit acquisition arrangement, indicating a strategic move to align director interests with company performance, potentially impacting stakeholder confidence positively.
The most recent analyst rating on (AU:HCW) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on HealthCo Healthcare & Wellness REIT stock, see the AU:HCW Stock Forecast page.
HealthCo Healthcare & Wellness REIT has released its corporate governance statement for the financial year ending June 30, 2025. The statement, approved by the board, outlines the extent to which the company has adhered to the ASX Corporate Governance Council’s recommendations. The company has chosen to publish this statement on its website, ensuring transparency and compliance with ASX listing rules. This move highlights the company’s commitment to maintaining robust governance practices, which is crucial for its stakeholders and industry positioning.
The most recent analyst rating on (AU:HCW) stock is a Sell with a A$1.04 price target. To see the full list of analyst forecasts on HealthCo Healthcare & Wellness REIT stock, see the AU:HCW Stock Forecast page.
HealthCo Healthcare & Wellness REIT has released its FY25 results, acknowledging the Traditional Custodians of Country throughout Australia and celebrating their diverse culture. The announcement reflects the company’s commitment to respecting Aboriginal and Torres Strait Islander peoples, although specific financial or operational impacts are not detailed in the release.
The most recent analyst rating on (AU:HCW) stock is a Sell with a A$1.04 price target. To see the full list of analyst forecasts on HealthCo Healthcare & Wellness REIT stock, see the AU:HCW Stock Forecast page.
HealthCo Healthcare & Wellness REIT reported its FY25 results, highlighting a Funds From Operations (FFO) of 6.6 cents per unit and a Distribution Per Unit (DPU) of 4.2 cents. The company maintains a strong balance sheet with $103.8 million in cash and undrawn debt, and a gearing ratio of 31%. The REIT’s portfolio boasts a 99% occupancy rate and a 5.2% like-for-like Net Operating Income (NOI) growth. Amidst the ongoing Healthscope sale process, HealthCo is working with the Receiver to ensure continuity of services and is prepared to re-tenant its hospitals if necessary. The company’s outlook for FY26 includes resuming distributions post-resolution of the Healthscope situation, emphasizing its commitment to maintaining essential healthcare services.
The most recent analyst rating on (AU:HCW) stock is a Sell with a A$1.04 price target. To see the full list of analyst forecasts on HealthCo Healthcare & Wellness REIT stock, see the AU:HCW Stock Forecast page.
HealthCo Healthcare and Wellness REIT reported a significant financial downturn for the year ending June 30, 2025, with a 17% drop in revenues from ordinary activities and a 1387% decrease in profit after tax. The company attributed these losses to reduced income from equity-accounted investees and decided not to declare further distributions to preserve balance sheet liquidity. Despite these challenges, the company maintained its interim distributions and continued its strategic focus on healthcare and wellness properties.
The most recent analyst rating on (AU:HCW) stock is a Sell with a A$1.04 price target. To see the full list of analyst forecasts on HealthCo Healthcare & Wellness REIT stock, see the AU:HCW Stock Forecast page.
HealthCo Healthcare & Wellness REIT announced a change in its registered office and principal place of business, effective August 11, 2025, moving to Level 31, Gateway, 1 Macquarie Place, Sydney. This relocation could signify strategic positioning within the industry, potentially impacting its operational efficiency and stakeholder engagement.
The most recent analyst rating on (AU:HCW) stock is a Sell with a A$1.04 price target. To see the full list of analyst forecasts on HealthCo Healthcare & Wellness REIT stock, see the AU:HCW Stock Forecast page.